PATH Vaccine Solutions
Seattle, Washington, United States
Purpose
to advance early clinical development of the bovine-human reassortant rotavirus strains (BRV) candidate ultimately expanding the global rotavirus vaccine market to increase affordability and improve access
Division
Global Health
Date
October 2014
Region Served
GLOBAL
Committed amount
$2,400,538
Grant topic
Enterics, Diagnostics, Genomics & Epidemiology
Duration (months)
62
Grantee location
Seattle, Washington, United States
More about our financials
Our story
Learn about the origins of the foundation and the values that drive our work.
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.